Milionis H J, Kalantzi K J, Goudevenos J A, Seferiadis K, Mikhailidis D P, Elisaf M S
Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece.
J Intern Med. 2005 Nov;258(5):435-41. doi: 10.1111/j.1365-2796.2005.01565.x.
Elevated serum uric acid (SUA) levels have been proposed as an independent risk factor for cardiovascular (CV) morbidity and mortality. Recent evidence suggests that treatments with a hypouricaemic action have a favourable effect on CV event prevention.
The association between SUA and acute ischaemic/non-embolic stroke was assessed in a population-based case-control study in the prefecture of Ioannina, Epirus, Greece.
A total of 163 patients aged older than 70 years (88 men and 75 women) admitted due to a first-ever-in-a-lifetime acute ischaemic/non-embolic stroke and 166 volunteers (87 men and 79 women) without a history of CV disease were included. The association between SUA and stroke was determined by multivariate logistic regression modelling after adjusting for potential confounding factors.
Stroke patients showed higher concentrations of SUA compared with controls (333.1+/-101.1 micromol L(-1) vs. 285.5+/-83.3 micromol L(-1); P<0.001). In univariate analysis elevated SUA levels were associated with increased risk for ischaemic stroke [odds ratio (OR) 1.42, 95% confidence interval (CI) 1.21-1.64, P<0.0001]. Compared to patients with SUA levels in the lowest quintile, those within the highest quintile had a 2.8-time increase in the odds of suffering an ischaemic stroke (OR 2.81, 95% CI 1.67-4.73, P<0.001). This association was strong even after controlling for gender, age, body mass index, the presence of hypertension and diabetes mellitus, drug treatment and lipids (OR 2.90, 95% CI 1.59-5.30, P=0.001).
Elevated SUA is associated with an increased risk for acute ischaemic/non-embolic stroke in a strictly defined population of elderly individuals independently of concurrent metabolic derangements. This association may need to be considered when treating the elderly.
血清尿酸(SUA)水平升高已被认为是心血管(CV)发病和死亡的独立危险因素。最近的证据表明,具有降尿酸作用的治疗对预防心血管事件有积极作用。
在希腊伊庇鲁斯约阿尼纳州进行的一项基于人群的病例对照研究中,评估SUA与急性缺血性/非栓塞性中风之间的关联。
纳入了163例年龄大于70岁(88例男性和75例女性)因首次发生急性缺血性/非栓塞性中风而入院的患者以及166名无心血管疾病史的志愿者(87例男性和79例女性)。在对潜在混杂因素进行校正后,通过多因素逻辑回归模型确定SUA与中风之间的关联。
与对照组相比,中风患者的SUA浓度更高(333.1±101.1 μmol/L对285.5±83.3 μmol/L;P<0.001)。在单因素分析中,SUA水平升高与缺血性中风风险增加相关[比值比(OR)1.42,95%置信区间(CI)1.21 - 1.64,P<0.0001]。与SUA水平处于最低五分位数的患者相比,处于最高五分位数的患者发生缺血性中风的几率增加了2.8倍(OR 2.81,95% CI 1.67 - 4.73,P<0.001)。即使在控制了性别、年龄、体重指数、高血压和糖尿病的存在情况、药物治疗和血脂后,这种关联仍然很强(OR 2.90,95% CI 1.59 - 5.30,P = 0.001)。
在严格定义的老年人群中,SUA升高与急性缺血性/非栓塞性中风风险增加相关,且独立于并发的代谢紊乱。在治疗老年人时可能需要考虑这种关联。